Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
NCMI Stock Summary
Top 10 Correlated ETFs
NCMI
In the News
NCMI Financial details
Company Rating
Neutral
Market Cap
458.93M
Income
705.3M
Revenue
165.3M
Book val./share
4.49
Cash/share
0.39
Dividend
-
Dividend %
-
Employees
292
Optionable
No
Shortable
Yes
Earnings
07 May 2024
P/E
0.42
Forward P/E
-
PEG
-0
P/S
2.62
P/B
0.69
P/C
11.28
P/FCF
-12.27
Quick Ratio
1.67
Current Ratio
2
Debt / Equity
0.03
LT Debt / Equity
0.02
-
-
EPS (TTM)
31.34
EPS next Y
-
EPS next Q
-
EPS this Y
-522.06%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
5.61%
Revenue last 5Y
-17.97%
Revenue Q/Q
268.02%
EPS Q/Q
-91.72%
-
-
-
-
SMA20
-
SMA50
25%
SMA100
25%
Inst Own
0%
Inst Trans
0%
ROA
124%
ROE
-408%
ROC
0.02%
Gross Margin
86%
Oper. Margin
7%
Profit Margin
403%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.8-5.75
52W High
-12%
52W Low
+340%
RSI
41
Rel Volume
0.57
Avg Volume
694.67K
Volume
399.2K
Perf Week
-11.11%
Perf Month
2.56%
Perf Quarter
20.55%
Perf Half Y
15.18%
-
-
-
-
Beta
1.91
-
-
Volatility
0.22%, 0.54%
Prev Close
-1.12%
Price
4.4
Change
-5.17%
NCMI Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-28
Metric | History | 2019-12-26 | 2020-12-31 | 2021-12-30 | 2022-12-29 | 2023-12-28 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 57.51 | 11.6 | 14.35 | 30.4 | 3.45 | |
Net income per share | 11.21 | -16.2 | -14.21 | -3.49 | 14.73 | |
Operating cash flow per share | 18.57 | 7.09 | -11.92 | -5.77 | -0.16 | |
Free cash flow per share | 16.76 | 6.07 | -12.63 | -6.12 | -0.23 | |
Cash per share | 9.49 | 23.17 | 12.71 | 7.61 | 0.79 | |
Book value per share | -15.67 | -34.46 | -48.02 | -62.87 | 9.07 | |
Tangible book value per share | -98.89 | -114.99 | -123.93 | -128.18 | 0.84 | |
Share holders equity per share | -15.67 | -34.46 | -48.02 | -62.87 | 9.07 | |
Interest debt per share | 127.3 | 142.14 | 145.53 | 280 | 0.81 | |
Market cap | 558.44M | 290M | 219.64M | 19.67M | 206.85M | |
Enterprise value | 1.43B | 1.16B | 1.22B | 1.08B | 185.25M | |
P/E ratio | 6.44 | -2.3 | -1.94 | -0.69 | 0.29 | |
Price to sales ratio | 1.26 | 3.21 | 1.92 | 0.08 | 1.25 | |
POCF ratio | 3.89 | 5.24 | -2.31 | -0.42 | -26.18 | |
PFCF ratio | 4.31 | 6.13 | -2.18 | -0.39 | -18.47 | |
P/B Ratio | -4.61 | -1.08 | -0.57 | -0.04 | 0.48 | |
PTB ratio | -4.61 | -1.08 | -0.57 | -0.04 | 0.48 | |
EV to sales | 3.21 | 12.85 | 10.61 | 4.33 | 1.12 | |
Enterprise value over EBITDA | 7 | -54.81 | -36.96 | 24.03 | -102.92 | |
EV to operating cash flow | 9.95 | 21.01 | -12.77 | -22.81 | -23.45 | |
EV to free cash flow | 11.03 | 24.57 | -12.05 | -21.5 | -16.54 | |
Earnings yield | 0.16 | -0.44 | -0.52 | -1.45 | 3.41 | |
Free cash flow yield | 0.23 | 0.16 | -0.46 | -2.55 | -0.05 | |
Debt to equity | -7.65 | -3.92 | -2.86 | -4.3 | 0.03 | |
Debt to assets | 0.82 | 1.19 | 1.34 | 2.8 | 0.02 | |
Net debt to EBITDA | 4.27 | -41.13 | -30.28 | 23.59 | 12 | |
Current ratio | 2.13 | 4 | 2.27 | 0.14 | 2.46 | |
Interest coverage | 2.78 | -1.06 | -1.06 | 0.17 | -0.98 | |
Income quality | 1.66 | -0.44 | 0.8 | 0.71 | -0.01 | |
Dividend Yield | 0.22 | 0.24 | 0.08 | 0.48 | 0 | |
Payout ratio | 1.45 | -0.54 | -0.15 | -0.33 | 0 | |
Sales general and administrative to revenue | 0.1 | 0.34 | 0.31 | 0.18 | 0.35 | |
Research and developement to revenue | 0.01 | 0.02 | 0.01 | 0.02 | 0.02 | |
Intangibles to total assets | 0.57 | 0.71 | 0.74 | 0.74 | 0.69 | |
Capex to operating cash flow | -0.1 | -0.14 | 0.06 | 0.06 | 0.42 | |
Capex to revenue | -0.03 | -0.09 | -0.05 | -0.01 | -0.02 | |
Capex to depreciation | -0.35 | -0.21 | -0.16 | -0.09 | -0.13 | |
Stock based compensation to revenue | 0.01 | 0.02 | 0.07 | 0.03 | 0.03 | |
Graham number | 62.87 | 112.07 | 123.91 | 70.25 | 54.84 | |
ROIC | 0.17 | 0.26 | -0.09 | 0 | -0.06 | |
Return on tangible assets | 0.18 | -0.49 | -0.54 | -0.14 | 4.07 | |
Graham Net | -135.56 | -123.49 | -132.74 | -137.12 | -0.48 | |
Working capital | 134.8M | 149.9M | 88.6M | -1.04B | 85.4M | |
Tangible asset value | -764.9M | -896.4M | -989.8M | -1.05B | 40.2M | |
Net current asset value | -996.9M | -954.9M | -1.04B | -1.09B | 10.6M | |
Invested capital | -7.65 | -3.92 | -2.86 | -4.3 | 0.03 | |
Average receivables | 169.5M | 96.8M | 34.6M | 72.5M | 94.3M | |
Average payables | 19.35M | 17.2M | 15M | 20.65M | 23.35M | |
Average inventory | -8.85M | -4.35M | -1.1M | 550K | 1.05M | |
Days sales outstanding | 145.57 | 65.41 | 168.8 | 134.75 | 213.43 | |
Days payables outstanding | 197.27 | 485.49 | 323.34 | 335.48 | 75 | |
Days of inventory on hand | -71.48 | -42.52 | -19.84 | 28.18 | 0 | |
Receivables turnover | 2.51 | 5.58 | 2.16 | 2.71 | 1.71 | |
Payables turnover | 1.85 | 0.75 | 1.13 | 1.09 | 4.87 | |
Inventory turnover | -5.11 | -8.58 | -18.4 | 12.95 | 0 | |
ROE | -0.72 | 0.47 | 0.3 | 0.06 | 1.62 | |
Capex per share | -1.81 | -1.03 | -0.71 | -0.35 | -0.07 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-28 for Q4
Metric | History | 2022-12-29 | 2023-03-30 | 2023-06-29 | 2023-09-28 | 2023-12-28 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 11.66 | 2.4 | 0.85 | 0.39 | 0.94 | |
Net income per share | -1.51 | -3.13 | 31.33 | 2.9 | 0.24 | |
Operating cash flow per share | -1.35 | 0.71 | -0.34 | -0.43 | 0.16 | |
Free cash flow per share | -1.46 | 0.65 | -0.34 | -0.44 | 0.14 | |
Cash per share | 7.93 | 4.79 | 0.95 | 0.27 | 0.39 | |
Book value per share | -65.5 | -36.55 | -1.11 | 6.52 | 4.49 | |
Tangible book value per share | -133.55 | -76.47 | -1.11 | 0.01 | 4.49 | |
Share holders equity per share | -65.5 | -36.55 | -1.11 | 6.52 | 4.49 | |
Interest debt per share | 284.43 | 78.68 | 0.18 | 0.27 | 0.12 | |
Market cap | 18.88M | 20.37M | 55.7M | 279.31M | 418.22M | |
Enterprise value | 1.08B | 1.07B | 40.2M | 278.51M | 396.62M | |
P/E ratio | -0.4 | -0.11 | 0.03 | 0.38 | 4.41 | |
Price to sales ratio | 0.21 | 0.58 | 3.76 | 11.31 | 4.6 | |
POCF ratio | -1.78 | 1.96 | -9.44 | -10.42 | 26.81 | |
PFCF ratio | -1.64 | 2.17 | -9.28 | -10.19 | 29.87 | |
P/B Ratio | -0.04 | -0.04 | -2.89 | 0.68 | 0.96 | |
PTB ratio | -0.04 | -0.04 | -2.89 | 0.68 | 0.96 | |
EV to sales | 11.76 | 30.72 | 2.72 | 11.28 | 4.36 | |
Enterprise value over EBITDA | 29.79 | -46.42 | -10.58 | -46.42 | 12.75 | |
EV to operating cash flow | -101.72 | 103.1 | -6.81 | -10.39 | 25.42 | |
EV to free cash flow | -93.76 | 114.07 | -6.7 | -10.16 | 28.33 | |
Earnings yield | -0.63 | -2.23 | 9.79 | 0.65 | 0.06 | |
Free cash flow yield | -0.61 | 0.46 | -0.11 | -0.1 | 0.03 | |
Debt to equity | -4.3 | -2.11 | 0 | 0.04 | 0.03 | |
Debt to assets | 2.8 | 1.51 | 0 | 0.03 | 0.02 | |
Net debt to EBITDA | 29.27 | -45.54 | 4.08 | 0.13 | -0.69 | |
Current ratio | 0.14 | 0.1 | 2.43 | 2 | 2.46 | |
Interest coverage | 1.25 | -1.28 | -1.58 | -41 | 51.25 | |
Income quality | -1.05 | -0.19 | -0.01 | -0.15 | 0.66 | |
Dividend Yield | 0 | 0.02 | 0 | 0 | 0 | |
Payout ratio | 0 | -0.01 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.15 | 0.6 | 0.84 | 0.3 | 0.18 | |
Research and developement to revenue | 0.01 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.74 | 0.78 | 0 | 0.76 | 0.69 | |
Capex to operating cash flow | 0.08 | -0.1 | 0.02 | 0.02 | -0.1 | |
Capex to revenue | -0.01 | -0.03 | -0.01 | -0.02 | -0.02 | |
Capex to depreciation | -0.12 | -0.13 | -0.09 | -0.1 | -0.15 | |
Stock based compensation to revenue | 0.02 | 0.04 | 0.03 | 0.04 | 0.02 | |
Graham number | 47.21 | 50.71 | 27.96 | 20.62 | 4.97 | |
ROIC | -0.02 | -0.04 | 0.25 | -0.03 | 0.05 | |
Return on tangible assets | -0.06 | -0.29 | 12.56 | 1.4 | 0.14 | |
Graham Net | -142.86 | -80.54 | -2.65 | -0.83 | -0.24 | |
Working capital | -1.04B | -1.08B | 14M | 51.6M | 85.4M | |
Tangible asset value | -1.05B | -1.11B | -19.3M | 400K | 40.2M | |
Net current asset value | -1.09B | -1.15B | -38.9M | -26.3M | 10.6M | |
Invested capital | -4.3 | -2.11 | 0 | 0.04 | 0.03 | |
Average receivables | 75.4M | 65.6M | 19.7M | 34.75M | 82.95M | |
Average payables | 21.65M | 24.5M | 13.2M | 10.6M | 20.25M | |
Average inventory | 550K | 2.1M | 1.05M | 8.2M | 8.2M | |
Days sales outstanding | 90.29 | 101.09 | 1.22 | 252.51 | 95.64 | |
Days payables outstanding | 284.81 | 61.36 | 35.41 | 72.31 | 47.63 | |
Days of inventory on hand | 23.92 | 5.37 | 0 | 63.08 | 0 | |
Receivables turnover | 1 | 0.89 | 74 | 0.36 | 0.94 | |
Payables turnover | 0.32 | 1.47 | 2.54 | 1.24 | 1.89 | |
Inventory turnover | 3.76 | 16.76 | 0 | 1.43 | 0 | |
ROE | 0.02 | 0.09 | -28.25 | 0.44 | 0.05 | |
Capex per share | -0.11 | -0.07 | -0.01 | -0.01 | -0.02 |
NCMI Frequently Asked Questions
What is National CineMedia, Inc. stock symbol ?
National CineMedia, Inc. is a US stock , located in Centennial of Co and trading under the symbol NCMI
What is National CineMedia, Inc. stock quote today ?
National CineMedia, Inc. stock price is $4.4 today.
Is National CineMedia, Inc. stock public?
Yes, National CineMedia, Inc. is a publicly traded company.